Patent details

EP2004683 Title: PC5 AS A FACTOR IX PROPEPTIDE PROCESSING ENZYME

Basic Information

Publication number:
EP2004683
PCT Application Number:
PCT/US/2007/007252
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP077538486
PCT Publication Number:
WO/2007/112005
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PC5 AS A FACTOR IX PROPEPTIDE PROCESSING ENZYME
French Title of Invention:
PROTÉINE PC5 UTILISÉE COMME ENZYME DE TRAITEMENT DU PROPEPTIDE DU FACTEUR IX
German Title of Invention:
PC5 ALS FAKTOR-IX-PROPEPTID-VERARBEITENDES ENZYM
SPC Number:

Dates

Filing date:
23/03/2007
Grant date:
11/05/2016
EP Publication Date:
11/05/2016
PCT Publication Date:
04/10/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/12/2008
EP B1 Publication Date:
11/05/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/03/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/06/2017
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

History of Owners

From:
23/03/2007
To:
28/06/2017

Name:
Biogen Hemophilia Inc.
Address:
250 Binney Street, Cambridge MA 02142, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
08/08/2016
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
PETERS Robert, T.
Address:
United States (US)

2

Name:
BITONTI Alan
Address:
United States (US)

Priority

Priority Number:
785421 P
Priority Date:
24/03/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/745;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20170000215A
Date Registered:
28/06/2017
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/03/2026
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
29/06/2017 Outgoing Correspondence 1
28/06/2017 Request For Change 6